Cargando…

The missing middle of sickle therapeutics: Multi‐agent therapy, targeting risk, using biomarkers

Detalles Bibliográficos
Autores principales:	Hebbel, Robert P., Elion, Jacques, Kutlar, Abdullah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2018
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283073/ https://www.ncbi.nlm.nih.gov/pubmed/30230577 http://dx.doi.org/10.1002/ajh.25289

Ejemplares similares

Altered VWF:ADAMTS13 homeostasis is a target for therapeutic intervention in sickle cell disease
por: Chaturvedi, Shruti, et al.
Publicado: (2022)

Invasive non-typhoidal Salmonella in sickle cell disease in Africa: is increased gut permeability the missing link?
por: Lim, Seah H., et al.
Publicado: (2018)

P-Selectin Blockade in the Treatment of Painful Vaso-Occlusive Crises in Sickle Cell Disease: A Spotlight on Crizanlizumab
por: Karki, Nabin Raj, et al.
Publicado: (2021)

Multiple inducers of endothelial NOS (eNOS) dysfunction in sickle cell disease
por: Hebbel, Robert P., et al.
Publicado: (2021)

Pathophysiological insights in sickle cell disease
por: Odièvre, Marie-Hélène, et al.
Publicado: (2011)

Cancer biomarkers and targeted therapies
por: Shen, Zhiyuan
Publicado: (2013)

Transfusion therapy for sickle cell disease: what’s new?
por: Chou, Stella T., et al.
Publicado: (2022)

Shock and kill, but don't miss the target
por: Herbein, Georges
Publicado: (2020)

Genetic risk factors for cerebrovascular disease in children with sickle cell disease: design of a case-control association study and genomewide screen
por: Adams, Gaye T, et al.
Publicado: (2003)

Editorial for Special Issue “Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies”
por: Colombatti, Raffaella, et al.
Publicado: (2019)

Bilirubin: A Potential Biomarker and Therapeutic Target for Diabetic Nephropathy
por: Hull, Travis D., et al.
Publicado: (2014)

Transgelin in bladder cancer: A potential biomarker and therapeutic target
por: Li, Wei-Ming, et al.
Publicado: (2019)

Fatty acid nitroalkenes – Multi-target agents for the treatment of sickle cell disease
por: Chowdhury, Fabliha A., et al.
Publicado: (2023)

Complement in Lupus: Biomarker, Therapeutic Target, or a Little Bit of Both?
por: Cantarelli, Chiara, et al.
Publicado: (2021)

Evaluation of Biomarkers for HER3-targeted Therapies in Cancer
por: Karachaliou, Niki, et al.
Publicado: (2015)

Epigenetics in rhabdomyosarcoma: cues to new biomarkers and targeted therapies
por: Megiorni, Francesca
Publicado: (2020)

Morphine promotes renal pathology in sickle mice
por: Weber, Marc L, et al.
Publicado: (2012)

Methods to handle missing values and missing individuals
por: Bonander, Carl, et al.
Publicado: (2018)

Plasma-type gelsolin in subarachnoid hemorrhage: novel biomarker today, therapeutic target tomorrow?
por: Chou, Sherry Hsiang-Yi, et al.
Publicado: (2014)

How benign is sickle cell trait?
por: Gibson, John S., et al.
Publicado: (2016)

Honey: A Therapeutic Agent for Disorders of the Skin
por: McLoone, Pauline, et al.
Publicado: (2016)

Membranous Nephropathy: The Journey Continues …
por: Hoxha, Elion, et al.
Publicado: (2015)

Cracking the cryptic code in amyotrophic lateral sclerosis and frontotemporal dementia: Towards therapeutic targets and biomarkers
por: Akiyama, Tetsuya, et al.
Publicado: (2022)

Sickle cell trait: A sigh of relief?
por: Wood, John C.
Publicado: (2019)

The hematopoietic saga of clonality in sickle cell disease
por: Stonestrom, Aaron J., et al.
Publicado: (2022)

Targeted Endocrine Agents should be the Dominant Systemic Therapies Prescribed in Luminal A Breast Cancer
por: Davey, Matthew G, et al.
Publicado: (2023)

Characteristics of sickle cell patients with frequent emergency department visits and hospitalizations
por: Kidwell, Kyle, et al.
Publicado: (2021)

Missing heritability, polygenic scores, and gene–environment correlation
por: Plomin, Robert
Publicado: (2013)

A Potent, Broad-Spectrum Antiviral Agent that Targets Viral Membranes
por: Wojcechowskyj, Jason A., et al.
Publicado: (2010)

Using organization theory to position middle-level managers as agents of evidence-based practice implementation
por: Birken, Sarah A., et al.
Publicado: (2021)

New therapeutic strategy for Alzheimer's disease using antidiabetes agents
por: Yokono, Koichi
Publicado: (2013)

Implications of COVID-19 infections in sickle cell disease
por: John, Nitin Ashok, et al.
Publicado: (2020)

DTDE: A new cooperative multi-agent reinforcement learning framework
por: Wen, Guanghui, et al.
Publicado: (2021)

Mucosal Lining Fluid Biomarkers in Asthma: Basis for Rational Use of New Targeted Therapies?
por: Valenta, Rudolf
Publicado: (2017)

Don’t miss the diagnosis of sepsis!
por: Marik, Paul E
Publicado: (2014)

The Long and the Short of Missing Medicines
por: Horgan, Denis, et al.
Publicado: (2017)

Commentary: Case of the missing message
por: Goldman, Scott
Publicado: (2020)

A monocyte‐TNF‐endothelial activation axis in sickle transgenic mice: Therapeutic benefit from TNF blockade
por: Solovey, Anna, et al.
Publicado: (2017)

Mental health near miss indicators in maternity care: a missed opportunity? A commentary
por: Easter, A, et al.
Publicado: (2017)

O-06: E-SICKLE CELL DISEASE: A FRENCH SPEAKING TRAINING PLATFORM TARGETING ALL LEVELS OF THE HEALTHCARE SYSTEM
por: M., COLLIN, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jtiplm5g05gg80e9i0pkks04m9